Our Sectors
We are experts at what we do
01
Our People
A dedicated team of executive search experts, delivering for you
The Compass Carter Osborne team are healthcare and life science experts. As a trusted advisor we bring decades of search experience and an unparalleled track record of delivery across our dedicated sectors for our investor clients – relied upon time and again to build outstanding leadership teams.
Familiar faces at key industry events, our expertise extends beyond the mere placing of people with our consultants bringing together sector leaders to address key challenges, working in partnership to produce tangible solutions.
02
Expertise
Unearthing rare talent, that drive successful exits
Responsive, adaptable, and emotionally intelligent, Compass Carter Osborne avoid the one-size-fits-all approach to ensure our clients achieve their desired outcome by presenting a broad range of intuitive, tailored solutions, based on specific needs.
03
Our Approach
Tailoring our offering,
to provide a bespoke service
Results driven, not process led, CCO avoid the conformity of a rigid process. Never assumptive, we listen and adopt an agreed approach which most closely delivers to a clients specific needs. Understanding the uniqueness of each role, our people tailor a search to bespoke requirements to ensure solutions that delivers the best possible results first time, every time.
A trusted advisor to the investment community
providing leaders advancing the healthcare and life sciences sectors
What our clients say
“Compass Carter Osborne really delivered for us in our search for a new CEO for Outcomes First Group. It was a vitally important assignment given that we were recruiting a successor for a long standing and highly successful CEO in a sector-leading business. Compass Carter Osborne went above and beyond in developing a deep understanding of the business and our requirements, and in only presenting candidates that closely met these. They think very creatively and their focus was very sharp; they particularly understood the culture of the business. The search was speedy and well organised, with a very high standard of verbal and written feedback. They have a granular knowledge of the sector and because of the way in which they work, we were fully involved throughout and achieved a great result. A really excellent search – thank you.”
Outcomes First Group – Chair
“Compass Carter Osborne started from the very beginning with a detailed, professional explanation of the available position. They spent time to present the great opportunity and chance to accelerate my career but at the same time, the challenge, and the strong expectation from their client.”
Hengrui Therapeutics – VP, Head Biological Drug Discovery
“Compass Carter Osborne delivered on a key appointment for the PFA and the wider football industry. It was a complex brief involving creating an entirely new position. The role was vitally important, with the successful candidate taking on a sensitive and multifaceted responsibility across CTE, concussion and brain health in professional football. CCO led a comprehensive and exhaustive process, developing a deep understanding of the union’s requirements and using his expert knowledge to help scope and evolve the brief throughout the search. The entire process was professional, efficient and well organised, with consistent communication and feedback at every stage.”
The Professional Footballers Association (PFA) – Chief Executive Officer
“I have been so impressed by Luke’s integrity, clear purpose and drive to achieve for his clients. Luke has worked with Priory on a number of things but more recently to source two independent Non Executive Directors and a Director of Talent Acquisition. He has kept us informed, fielded some great candidates and follows up at each stage, even when they have started. I would really recommend him if you are searching for high calibre individuals.”
Priory Group – Chief Executive Officer
“I recently had the pleasure of being appointed to an independent healthcare provider as a NED after being put forward for the role by Luke. Throughout the whole recruitment process I was treated with respect and felt valued. I was particularly impressed with the follow up support after the decision to appoint me, which I have never experienced from other search companies. Luke continued to check in with me to ensure my onboarding went smoothly and that I had settled into the role. Overall, a highly professional and comprehensive approach delivered personally by Luke.”
Priory – Independent Non-Executive Director
“Luke was absolutely brilliant along the journey. He acted as a real partner and was able to answer to all my questions in order to get comfortable with the decision of making the change. His expertise and knowledge of the sector really came out along the process. Most importantly, he was always available when I needed him to be, which is something I valued a lot. In summary, I couldn’t recommend him and Compass Carter Osborne enough.”
AniCura – Group Chief Operating Officer
“We worked with Compass Carter Osborne in the search for our Chief Financial Officer and from the start it was clear they were a good choice of partner. A focus on understanding our needs as a business, and mine personally as a CEO were front of mind for Paul and Kieran. They took the time to listen, understand and not only focus on the functional aspects of the role – but critically, the team fit and culture we are building.
Process, structure and follow-through were like clockwork, and the quality of candidates were of a consistently high-level. I would highly recommend Compass Carter Osborne.”
Renaiss Health – Chief Executive Officer
“I’ve known Tarquin for over 15 years, during which time he has delivered a number of executive assignments at senior level, including COO/executive team and senior management roles in scientific/professional disciplines (his network in the biotech/life-sciences sector is second-to-none!). He works hard to truly understand both the candidate brief and the culture of the company, sets realistic expectations and retains regular contact as an assignment progresses, always providing thorough updates and pragmatic advice. He has the highest levels of professionalism and integrity – he really is a pleasure to work with.”
One Nucleus – Director
“Jamie did a great job – he really took the time to understand our business, our needs and what we were looking for. We knew our brief was specific, yet Jamie met all our expectations with the search. He maintained a high standard of communication and meticulous attention to detail throughout the process. I would recommend Jamie and the Compass Carter Osborne team without hesitation.”
Melrose Education – Chair & CEO
“Our recent work with Compass Carter Osborne was exceptional. The search was perfectly organised, response times were swift, and due to the consultant market knowledge and network, we quickly found our ideal candidate.”
Schoen Clinic – Member of Group Executive
Healthcare news, data and analysis
Via Investors in Healthcare
Germany: Alvia Capital acquires Luebeck-based care provider DAHEIM
DAHEIM Group, a leading care service provider in Schleswig-Holstein, has found a long-term partner for the future in the holding company Alvia Capital, a specialist in the healthcare and social […]
DAHEIM Group, a leading care service provider in Schleswig-Holstein, has found a long-term partner for the future in the holding company Alvia Capital, a specialist in the healthcare and social […]
Germany: Alvia Capital acquires Luebeck-based care provider DAHEIM
December 17, 2025
Buy Out
Homecare
M&A
News
Social Care
Italy: BNP Paribas REIM acquires majority stake in portfolio of 23 care facilities in Italy
BNP Paribas REIM has taken a major step forward for its HPF Europe fund (Healthcare Property Fund Europe) with the acquisition of a majority stake in Vita, a landmark Italian […]
BNP Paribas REIM has taken a major step forward for its HPF Europe fund (Healthcare Property Fund Europe) with the acquisition of a majority stake in Vita, a landmark Italian […]
Italy: BNP Paribas REIM acquires majority stake in portfolio of 23 care facilities in Italy
December 17, 2025
Care Homes
M&A
M&A Deals
News
Real Assets
The Netherlands: Asker expanding presence in Benelux with proposed acquisition of Ven Heek Medical
Nasdaq Stockholm-listed Asker Healthcare Group, a leading provider of medical products and solutions in Europe, has signed an agreement to acquire 100% of the shares in Allion (Van Heek Medical), […]
Nasdaq Stockholm-listed Asker Healthcare Group, a leading provider of medical products and solutions in Europe, has signed an agreement to acquire 100% of the shares in Allion (Van Heek Medical), […]
The Netherlands: Asker expanding presence in Benelux with proposed acquisition of Ven Heek Medical
December 17, 2025
Digital Health/Healthtech
Distribution
Healthcare
M&A
News
UK: MML Capital Partners closes Keystone I at €935m
MML Capital Partners has announced the final close of MML Keystone I and accompanying co-investment and managed vehicles, raising €935m (US$1.1bn). “Raising over €900m for a first-time strategy is a […]
MML Capital Partners has announced the final close of MML Keystone I and accompanying co-investment and managed vehicles, raising €935m (US$1.1bn). “Raising over €900m for a first-time strategy is a […]
UK: MML Capital Partners closes Keystone I at €935m
December 17, 2025
Education
Healthcare
News
Real Assets
Andrew Honan
India: Quadria Capital sells partial stake in Nephrocare’s IPO
Quadria Capital, one of Asia’s largest healthcare-focused private equity firms, has sold a partial stake in Nephrocare Health Services, one of the largest dialysis service networks in India, as part […]
Quadria Capital, one of Asia’s largest healthcare-focused private equity firms, has sold a partial stake in Nephrocare Health Services, one of the largest dialysis service networks in India, as part […]
India: Quadria Capital sells partial stake in Nephrocare’s IPO
December 17, 2025
Diagnostics
Healthcare
IVD – Tools
Life Sciences
Medtech – Diagnostics
Private capital opportunities in UK’s expanding SEN market
The UK’s special educational needs (SEN) sector is at a critical juncture. The pressures are both structural and acute. Rising diagnoses of autism, ADHD and other conditions, accelerated by the […]
The UK’s special educational needs (SEN) sector is at a critical juncture. The pressures are both structural and acute. Rising diagnoses of autism, ADHD and other conditions, accelerated by the […]
Private capital opportunities in UK’s expanding SEN market
December 16, 2025
Analysis
Education
SEN Schools
LEK
Louisa Chaves
France: Fremman and Chequers enter into a put option agreement to acquire Bertin Technologies
France-headquartered Chequers Capital, a pan-European mid-market private equity firms, and fellow pan-European, mid-market investment firm, Fremman Capital, have announced the execution of a put option agreement to acquire Bertin Technologies, […]
France-headquartered Chequers Capital, a pan-European mid-market private equity firms, and fellow pan-European, mid-market investment firm, Fremman Capital, have announced the execution of a put option agreement to acquire Bertin Technologies, […]
France: Fremman and Chequers enter into a put option agreement to acquire Bertin Technologies
December 16, 2025
Buy Out
News
Pharma
Services – CRO/CMO/CDMO
Andrea Bossetti
Finland: Northern Horizon expands care portfolio in Finland
Northern Horizon, a specialist social infrastructure asset manager in the Nordics, has expanded its care portfolio in Finland with the acquisition of three new assets for its latest healthcare fund. […]
Northern Horizon, a specialist social infrastructure asset manager in the Nordics, has expanded its care portfolio in Finland with the acquisition of three new assets for its latest healthcare fund. […]
Finland: Northern Horizon expands care portfolio in Finland
December 16, 2025
Care Homes
Complex Behavioural Care
M&A
M&A Deals
News
India: KKR’s Healthium Medtech to acquire controlling stake in Paramount Surgimed
Healthium Medtech, an India-based global medical devices company focused on products used in surgical, post-surgical and chronic care, has agreed to acquire a controlling stake in Paramount Surgimed, an Indian manufacturer […]
Healthium Medtech, an India-based global medical devices company focused on products used in surgical, post-surgical and chronic care, has agreed to acquire a controlling stake in Paramount Surgimed, an Indian manufacturer […]
India: KKR’s Healthium Medtech to acquire controlling stake in Paramount Surgimed
December 16, 2025
Buy Out
Life Sciences
M&A
Medtech – Hospital Equipment
Medtech – Medical Devices and Implants
France: Orphalan acquires Orphelia Pharma to strengthen global commercial footprint in rare diseases
France-headquartered Orphalan, a global pharmaceutical company specialising in the development and commercialisation of orphan drugs, has acquired Orphelia Pharma, a French pharmaceutical company dedicated to rare and serious paediatric diseases, […]
France-headquartered Orphalan, a global pharmaceutical company specialising in the development and commercialisation of orphan drugs, has acquired Orphelia Pharma, a French pharmaceutical company dedicated to rare and serious paediatric diseases, […]
France: Orphalan acquires Orphelia Pharma to strengthen global commercial footprint in rare diseases
December 15, 2025
M&A
News
Advent Life Sciences
BPIfrance
France
Sweden: Sobi strengthens gout pipeline with acquisition of Arthrosi Therapeutics
Nasdaq Stockholm-listed Swedish Orphan Biovitrum (SOBI), a global biopharma company, is to acquire US-based Arthrosi Therapeutics, a clinical-stage biotech company focused on the development of therapy for gout and chronic kidney […]
Nasdaq Stockholm-listed Swedish Orphan Biovitrum (SOBI), a global biopharma company, is to acquire US-based Arthrosi Therapeutics, a clinical-stage biotech company focused on the development of therapy for gout and chronic kidney […]
Sweden: Sobi strengthens gout pipeline with acquisition of Arthrosi Therapeutics
December 15, 2025
Debt
M&A
Manufacturing – Specialty Pharma
News
Pharma
UK: Person Centred Software raises new debt financing to fund combination with Clearcare
Person Centred Software (PCS), a UK care management software provider, has raised new debt financing, proceeds of which, combined with a concurrent equity raise provided by Brighton Park Capital (BPC), to […]
Person Centred Software (PCS), a UK care management software provider, has raised new debt financing, proceeds of which, combined with a concurrent equity raise provided by Brighton Park Capital (BPC), to […]
UK: Person Centred Software raises new debt financing to fund combination with Clearcare
December 15, 2025
Debt
Digital Health/Healthtech
Healthcare
News
Brighton Park Capital
Switzerland: SK Capital invests in Swixx Biopharma to accelerate growth
France-based Mérieux Equity Partners (MxEP), Swiss listed HBM Healthcare Investments (HBM) and founders have agreed to sell a majority stake in Swixx Biopharma to US-based SK Capital. The transaction, which […]
France-based Mérieux Equity Partners (MxEP), Swiss listed HBM Healthcare Investments (HBM) and founders have agreed to sell a majority stake in Swixx Biopharma to US-based SK Capital. The transaction, which […]
Switzerland: SK Capital invests in Swixx Biopharma to accelerate growth
December 15, 2025
Buy Out
M&A
News
Pharma
Services – CRO/CMO/CDMO
Spain: Carbyne Equity enters nutraceutical sector with acquisition of SuanNutra
Germany-based Carbyne Equity Partners has acquired the nutraceutical ingredients business of Archimed portfolio company Suanfarma, Spain-based SuanNutra. The carve out marks Carbyne’s entry into the nutraceutical sector and aligns with its […]
Germany-based Carbyne Equity Partners has acquired the nutraceutical ingredients business of Archimed portfolio company Suanfarma, Spain-based SuanNutra. The carve out marks Carbyne’s entry into the nutraceutical sector and aligns with its […]
Spain: Carbyne Equity enters nutraceutical sector with acquisition of SuanNutra
December 12, 2025
Buy Out
M&A
News
ArchiMed
Benoit Varichon
Slovenia: Great Point Partners acquires majority stake in Slovenian distributor Lenis Group
Great Point Partners (GPP), a US-based healthcare-focused private investment firm, has acquired a majority stake in Lenis Group, a Slovenian-based full-service regional commercialisation and distribution partner for niche and specialty […]
Great Point Partners (GPP), a US-based healthcare-focused private investment firm, has acquired a majority stake in Lenis Group, a Slovenian-based full-service regional commercialisation and distribution partner for niche and specialty […]
Slovenia: Great Point Partners acquires majority stake in Slovenian distributor Lenis Group
December 12, 2025
Buy Out
Distribution
Healthcare
M&A
News
US: Montagu and Kohlberg to carve out Teleflex Medical OEM for US$1.5bn
Europe-based Montagu and US-based Kohlberg, two middle-market PE firms, are to acquire Teleflex Medical OEM from New York-listed Teleflex for US$1.5bn. Following transaction close, the company will operate as an […]
Europe-based Montagu and US-based Kohlberg, two middle-market PE firms, are to acquire Teleflex Medical OEM from New York-listed Teleflex for US$1.5bn. Following transaction close, the company will operate as an […]
US: Montagu and Kohlberg to carve out Teleflex Medical OEM for US$1.5bn
December 10, 2025
Buy Out
M&A
News
Pharma
Services – CRO/CMO/CDMO
Switzerland: Alcon agrees best and final offer with STAAR Surgical
SIX-listed Alcon, the largest eye care device company in the world, has entered into an amended merger agreement for the acquisition of Nasdaq-listed STAAR Surgical Company, the designer, developer and […]
SIX-listed Alcon, the largest eye care device company in the world, has entered into an amended merger agreement for the acquisition of Nasdaq-listed STAAR Surgical Company, the designer, developer and […]
Switzerland: Alcon agrees best and final offer with STAAR Surgical
December 10, 2025
M&A
News
Public Equity
Alcon
David Endicott
The UK as a global life sciences hub: Legal infrastructure and innovation policy
To attract global investment and foster innovation in its life sciences sector, Britain must reshape its legal and policy frameworks, writes Clare Auty, partner and head of independent health and […]
To attract global investment and foster innovation in its life sciences sector, Britain must reshape its legal and policy frameworks, writes Clare Auty, partner and head of independent health and […]
The UK as a global life sciences hub: Legal infrastructure and innovation policy
December 9, 2025
Analysis
Legal
Life Sciences
News
Pharma
France: EQT to exit Colisée as part of financial recapitalisation plan
Colisée, a France-based European private-sector provider of support and care for the elderly and the fourth-largest private operator of nursing homes in Europe, has announced the signing of a lock-up […]
Colisée, a France-based European private-sector provider of support and care for the elderly and the fourth-largest private operator of nursing homes in Europe, has announced the signing of a lock-up […]
France: EQT to exit Colisée as part of financial recapitalisation plan
December 9, 2025
Care Homes
Debt
News
Social Care
Arnaud Marion
Belgium: PAI Partners acquires Innovad Group from IK Partners
French private equity firm, PAI Partners, is to acquire Belgium-based Innovad Group, a provider of animal nutrition and health solutions, from IK Partners (IK IX Fund), a European mid-market private […]
French private equity firm, PAI Partners, is to acquire Belgium-based Innovad Group, a provider of animal nutrition and health solutions, from IK Partners (IK IX Fund), a European mid-market private […]
Belgium: PAI Partners acquires Innovad Group from IK Partners
December 8, 2025
Animal Health
Buy Out
M&A
News
Veterinary
Switzerland: L’Oréal to double stake in Galderma
SIX-listed Galderma Group, a global pure-play dermatology company, has announced that L’Oréal Groupe intends to increase its equity investment in the company, acquiring an additional 10% stake from Sunshine SwissCo (a consortium […]
SIX-listed Galderma Group, a global pure-play dermatology company, has announced that L’Oréal Groupe intends to increase its equity investment in the company, acquiring an additional 10% stake from Sunshine SwissCo (a consortium […]
Switzerland: L’Oréal to double stake in Galderma
December 8, 2025
Consumer Healthcare
Cosmetic & Aesthetics
Healthcare
News
Public Equity
UK: British Business Bank to commit US$100m to SV Health Investors’ SV8 Biotech
The British Business Bank has agreed a US$100m cornerstone commitment to SV Health Investors’ new flagship fund, SV8 Biotech Fund, a multi-stage therapeutics-dedicated fund. The commitment supports the UK’s Life Sciences […]
The British Business Bank has agreed a US$100m cornerstone commitment to SV Health Investors’ new flagship fund, SV8 Biotech Fund, a multi-stage therapeutics-dedicated fund. The commitment supports the UK’s Life Sciences […]
UK: British Business Bank to commit US$100m to SV Health Investors’ SV8 Biotech
December 8, 2025
Life Sciences
News
Venture
British Business Bank
Leandros Kalisperas
Belgium: Care Property Invest acquires nine operational healthcare real estate projects in Belgium
Care Property Invest has acquired nine operational healthcare real estate projects in Belgium from Clariane for approximately €142.6m (US$166m). Clariane’s 52.2% ownership in the portfolio amounts to approximately €74m. The […]
Care Property Invest has acquired nine operational healthcare real estate projects in Belgium from Clariane for approximately €142.6m (US$166m). Clariane’s 52.2% ownership in the portfolio amounts to approximately €74m. The […]
Belgium: Care Property Invest acquires nine operational healthcare real estate projects in Belgium
December 8, 2025
Care Homes
M&A
M&A Deals
News
Public Equity
Switzerland: Galderma rated BBB by S&P with positive outlook
Six-listed Galderma, a global pure-play manufacturer of dermatology products, has received a BBB long-term issuer credit rating with a positive outlook from S&P. The rating reflects Galderma’s strong track record […]
Six-listed Galderma, a global pure-play manufacturer of dermatology products, has received a BBB long-term issuer credit rating with a positive outlook from S&P. The rating reflects Galderma’s strong track record […]
Switzerland: Galderma rated BBB by S&P with positive outlook
December 5, 2025
Cosmetic & Aesthetics
Debt
Healthcare
News
Galderma
France: Asker makes first add-on in France with acquisition of Cardio Dépôt
Asker Healthcare Group, a Stockholm-listed provider of medical products and solutions to the European healthcare sector, has acquired Cardio Dépôt, a niche distributor of medical devices and consumables within cardiology […]
Asker Healthcare Group, a Stockholm-listed provider of medical products and solutions to the European healthcare sector, has acquired Cardio Dépôt, a niche distributor of medical devices and consumables within cardiology […]
France: Asker makes first add-on in France with acquisition of Cardio Dépôt
December 5, 2025
Digital Health/Healthtech
Healthcare
Life Sciences
M&A
Medtech – Healthcare IT
The latest insights from
Compass Carter Osborne
Digital transformation or change fatigue? Navigating tech in health and care
Digital transformation or change fatigue? Navigating tech in health and care
November 24, 2025
Healthcare
Insight
Culture in flux: rebuilding trust in a multi-generational workforce
Culture in flux: rebuilding trust in a multi-generational workforce
October 24, 2025
Healthcare
Insight
